188 related articles for article (PubMed ID: 31653348)
1. High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.
Xie B; He X; Guo G; Zhang X; Li J; Liu J; Lin Y
Biochem Biophys Res Commun; 2020 Jan; 521(1):232-237. PubMed ID: 31653348
[TBL] [Abstract][Full Text] [Related]
2. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
[TBL] [Abstract][Full Text] [Related]
3. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z
Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631
[TBL] [Abstract][Full Text] [Related]
4. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo.
Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
Biochem Biophys Res Commun; 2016 Nov; 480(3):334-340. PubMed ID: 27756618
[TBL] [Abstract][Full Text] [Related]
5. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
6. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
7. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells.
Peng WX; Xiong EM; Ge L; Wan YY; Zhang CL; Du FY; Xu M; Bhat RA; Jin J; Gong AH
Exp Cell Res; 2016 Jan; 340(1):62-70. PubMed ID: 26708617
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells.
Tong Y; Huang H; Pan H
Biochem Biophys Res Commun; 2015 Jan; 456(1):86-91. PubMed ID: 25446102
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
10. Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma.
Yang X; Xie J; Liu X; Li Z; Fang K; Zhang L; Han M; Zhang Z; Gong Z; Lin X; Shi X; Gao H; Lu K
Cell Biochem Funct; 2019 Apr; 37(3):128-138. PubMed ID: 30883849
[TBL] [Abstract][Full Text] [Related]
11. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
12. Daurisoline inhibits hepatocellular carcinoma progression by restraining autophagy and promoting cispaltin-induced cell death.
Xue L; Liu P
Biochem Biophys Res Commun; 2021 Jan; 534():1083-1090. PubMed ID: 33213840
[TBL] [Abstract][Full Text] [Related]
13. Gamabufotalin Induces Apoptosis and Cytoprotective Autophagy through the mTOR Signaling Pathway in Hepatocellular Carcinoma.
Liu L; Shi D; Xia ZY; Wang BW; Wang XL; Wang XT; Wang GL; Li MJ; Zheng QS; Li D; Li BH
J Nat Prod; 2023 Apr; 86(4):966-978. PubMed ID: 37043698
[TBL] [Abstract][Full Text] [Related]
14. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
15. Synthetic strigolactone analogues reveal anti-cancer activities on hepatocellular carcinoma cells.
Hasan MN; Choudhry H; Razvi SS; Moselhy SS; Kumosani TA; Zamzami MA; Omran Z; Halwani MA; Al-Babili S; Abualnaja KO; Al-Malki AL; Alhosin M; Asami T
Bioorg Med Chem Lett; 2018 Apr; 28(6):1077-1083. PubMed ID: 29456109
[TBL] [Abstract][Full Text] [Related]
16. Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: a novel curcumin analog.
Zhou T; Ye L; Bai Y; Sun A; Cox B; Liu D; Li Y; Liotta D; Snyder JP; Fu H; Huang B
PLoS One; 2014; 9(9):e107876. PubMed ID: 25268357
[TBL] [Abstract][Full Text] [Related]
17. Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.
Bakhshi Aliabad H; Khanamani Falahati-Pour S; Ahmadirad H; Mohamadi M; Hajizadeh MR; Mahmoodi M
Biometals; 2018 Dec; 31(6):981-990. PubMed ID: 30255365
[TBL] [Abstract][Full Text] [Related]
18. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
19. Hydroxypyridinone-Coumarin Inhibits the Proliferation of MHCC97 and HepG2 Human Hepatocellular Carcinoma Cells and Down-Regulates the Phosphoinositide-3 Kinase Pathway.
Cui X; Qin X
Med Sci Monit; 2020 Mar; 26():e920785. PubMed ID: 32218414
[TBL] [Abstract][Full Text] [Related]
20. Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells.
Shen J; Zhu X; Wu Z; Shi Y; Wen T
Phytomedicine; 2022 Jan; 94():153793. PubMed ID: 34736000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
